Dashboard
Manage Tickers

ASMB


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

forecasting-the-future-4-analyst-projections-for-assembly-biosciences
Forecasting The Future: 4 Analyst Projecti...
10/14/2025 21:01:31

assembly-biosciences-files-prospectus-relates-to-offering-resale-from-time-to-time-of-up-to-698m-shares-by-selling-stockholder
Assembly Biosciences Files Prospectus Rela...
10/14/2025 20:24:26

- SEC Filing

hc-wainwright--co-reiterates-buy-on-assembly-biosciences-maintains-50-price-target
HC Wainwright & Co. Reiterates Buy on Asse...
10/14/2025 11:17:34

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Assembly Biosciences (NASDAQ:ASMB) with a Buy and maintains $...

assembly-biosciences-highlights-interim-phase-1b-clinical-data-for-long-acting-hsv-helicase-primase-inhibitor-candidate-abi-5366-in-late-breaking-oral-presentation-at-congress-of-iusti--europe
Assembly Biosciences Highlights Interim Ph...
10/10/2025 12:09:45

4-biotechnology-stocks-that-outshine-in-momentum-amid-strong-technicals
4 Biotechnology Stocks That Outshine In Mo...
09/29/2025 11:11:04

Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable week-on-week ...

jmp-securities-initiates-coverage-on-assembly-biosciences-with-market-outperform-rating-announces-price-target-of-38
JMP Securities Initiates Coverage On Assem...
09/24/2025 13:00:37

JMP Securities analyst Roy Buchanan initiates coverage on Assembly Biosciences (NASDAQ:ASMB) with a Market Outperform rating...

guggenheim-maintains-buy-on-assembly-biosciences-raises-price-target-to-39
Guggenheim Maintains Buy on Assembly Biosc...
09/08/2025 13:38:24

Guggenheim analyst Vamil Divan maintains Assembly Biosciences (NASDAQ:ASMB) with a Buy and raises the price target from $31 ...

hc-wainwright--co-assumes-assembly-biosciences-at-buy-announces-price-target-of-50
HC Wainwright & Co. Assumes Assembly Biosc...
08/18/2025 10:40:52

HC Wainwright & Co. analyst Patrick Trucchio assumes Assembly Biosciences (NASDAQ:ASMB) with a Buy rating and announces ...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/08/2025 21:08:06

assembly-biosciences-reports-interim-results-from-phase-1b-clinical-study-of-abi-5366-showing-94-reduction-in-hsv-2-shedding-rate-and-98-reduction-in-high-viral-load-shedding-rate
Assembly Biosciences Reports Interim Resul...
08/08/2025 12:09:44

assembly-biosciences-cash-cash-equivalents-and-marketable-securities-were-75m-projected-to-fund-operations-into-mid-2026
Assembly Biosciences' Cash, Cash Equivalen...
08/06/2025 21:08:20

assembly-biosciences-q2-2025-eps-133-beats-136-estimate-sales-9626m-beat-6262m-estimate
Assembly Biosciences Q2 2025 EPS $(1.33) B...
08/06/2025 21:07:32

assembly-biosciences-announced-interim-data-from-several-cohorts-from-the-ongoing-phase-1a-trial-of-abi-6250-for-hepatitis-delta-virus
Assembly Biosciences Announced Interim Dat...
08/06/2025 21:05:55

Data to date in single- and multiple-ascending dose cohorts of healthy participants demonstrate a four-day half-life for ABI-62...

reported-saturday-assembly-biosciences-presents-phase-1a-and-preclinical-data-for-abi-5366-and-abi-1179-herpes-candidates-at-sti--hiv-2025-and-international-herpesvirus-workshop
Reported Saturday, Assembly Biosciences Pr...
07/28/2025 06:23:26

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel long-acting herpes simplex vir...

assembly-biosciences-announces-topline-results-from-its-phase-1b-clinical-trial-of-next-generation-investigational-capsid-assembly-modulator-abi-4334-in-chronic-hepatitis-b
Assembly Biosciences Announces Topline Res...
06/25/2025 12:02:15

– Favorable safety and tolerability profile, as well as pharmacokinetics supporting once-daily oral dosing, continued to be obs...

syndeio-biosciences-launches-to-pioneer-precision-neurotherapeutics-focused-on-repairing-and-enhancing-synaptic-function-in-central-nervous-system-diseases
Syndeio Biosciences Launches To Pioneer Pr...
05/27/2025 11:07:36

Clinical portfolio, informed by deep and novel synapse biology and pharmacology insights, aims to strengthen neural connections...

assembly-biosciences-q1-eps-117-beats-160-estimate-sales-942m-beat-763m-estimate
Assembly Biosciences Q1 EPS $(1.17) Beats ...
05/08/2025 20:52:27

Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(1.17) per share which beat the analyst consensus estimate of ...

assembly-biosciences-releases-new-preclinical-date-for-oral-hepatitis-d-virus-entry-inhibitor-abi-6250-and-next-generation-hepatitis-b-virus-capsid-assembly-modulator-abi-4334-at-the-easl-congress-2025-in-amsterdam
Assembly Biosciences Releases New Preclini...
05/07/2025 12:09:44

– Late-breaker poster highlights preclinical profile of ABI-6250, currently in Phase 1a with data anticipated in Q3 2025 –– Sec...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
04/16/2025 12:07:22

assembly-biosciences-unveils-data-on-long-acting-hsv-candidate-abi-5366-and-us-genital-herpes-trends-at-2025-escmid-congress
Assembly Biosciences Unveils Data On Long-...
04/09/2025 06:27:52

– Clinical and preclinical data supporting dosing profile and tolerability for ABI-5366, a novel long-acting helicase-primase i...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION